Australian Clinical Labs Ltd Total Liabilities

Latest as of December 2025: AU$411.46 Million AUD ≈ $291.14 Million USD

Australian Clinical Labs Ltd total liabilities. Based on the latest financial reports, Australian Clinical Labs Ltd (ACL) has total liabilities worth AU$411.46 Million AUD (≈ $291.14 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check ACL asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Australian Clinical Labs Ltd (2016–2025)

Total liabilities of Australian Clinical Labs Ltd from 2016 to 2025. This chart illustrates how Australian Clinical Labs Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore long-term investment intensity of Australian Clinical Labs Ltd to see how much of total assets are deployed in long-term investments.

Australian Clinical Labs Ltd Competitors by Total Liabilities

The table below lists competitors of Australian Clinical Labs Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Volcon Inc NASDAQ:VLCN	USA	$4.12 Million
Nerdwallet Inc NASDAQ:NRDS	USA	$92.20 Million
Magnetic Resources NL AU:MAUCA	Australia	AU$1.40 Million
Civeo Corp NYSE:CVEO	USA	$308.52 Million
V.S.T Tillers Tractors Limited NSE:VSTTILLERS	India	Rs-10.94 Billion
Aduro Clean Technologies Inc. Common Stock NASDAQ:ADUR	USA	$18.35 Million
Avidia Bancorp, Inc. NYSE:AVBC	USA	$2.42 Billion
Jiangxi Selon Industrial Co Ltd SHE:002748	China	CN¥1.27 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Australian Clinical Labs Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Australian Clinical Labs Ltd assets under control.

Liquidity & Leverage Metrics

Australian Clinical Labs Ltd Total Liabilities Ratios Explained

Australian Clinical Labs Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	0.59	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.11	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.73	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.73	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Australian Clinical Labs Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Australian Clinical Labs Ltd (2016–2025)

The table below shows the annual total liabilities of Australian Clinical Labs Ltd from 2016 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$402.86 Million ≈ $285.05 Million	0.00%
2024-12-31	AU$402.86 Million ≈ $285.05 Million	-2.99%
2024-06-30	AU$415.30 Million ≈ $293.85 Million	0.00%
2023-12-31	AU$415.30 Million ≈ $293.85 Million	+2.23%
2023-06-30	AU$406.24 Million ≈ $287.44 Million	0.00%
2022-12-31	AU$406.24 Million ≈ $287.44 Million	+2.72%
2022-06-30	AU$395.49 Million ≈ $279.83 Million	0.00%
2021-12-31	AU$395.49 Million ≈ $279.83 Million	+0.69%
2021-06-30	AU$392.79 Million ≈ $277.92 Million	0.00%
2020-12-31	AU$392.79 Million ≈ $277.92 Million	+32.22%
2020-06-30	AU$297.06 Million ≈ $210.19 Million	0.00%
2019-12-31	AU$297.06 Million ≈ $210.19 Million	+135.41%
2019-06-30	AU$126.19 Million ≈ $89.29 Million	0.00%
2018-12-31	AU$126.19 Million ≈ $89.29 Million	+11.08%
2018-06-30	AU$113.60 Million ≈ $80.38 Million	0.00%
2017-12-31	AU$113.60 Million ≈ $80.38 Million	+6.40%
2017-06-30	AU$106.77 Million ≈ $75.55 Million	0.00%
2016-12-31	AU$106.77 Million ≈ $75.55 Million	--

About Australian Clinical Labs Ltd

AU:ACL Australia Diagnostics & Research

Market Cap

$438.21 Million

AU$619.32 Million AUD

Market Cap Rank

#13614 Global

#362 in Australia

Share Price

AU$3.30

Change (1 day)

+1.85%

52-Week Range

AU$1.84 - AU$3.30

All Time High

AU$5.09